Rajesh Kumar Thimmulappa

Rajesh Kumar Thimmulappa

Active Director Director DIN 09530912
DIN 09530912 First appointment Mar 2022 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajesh Kumar Thimmulappa

Data last updated:

Rajesh Kumar Thimmulappa is a Director at Fytomed Life Private Limited (since 2022). The company operates in Chemicals.

DIN 09530912
Primary Designation Director
Industry Chemicals
First Appointment 09 Mar 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Fytomed Life Private Limited U24230KA2022PTC158714
Director09 Mar 20222022Active

Board colleagues of Rajesh Kumar Thimmulappa

NameDINCompanyDesignation
Mudnakudu Nagaraju Kiran Kumar09530983Fytomed Life Private LimitedDirector

Directorship timeline

Open interactive timeline →
Fytomed Life Private Limited
Premium access

Shareholding and investment profile for Rajesh Kumar Thimmulappa

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Kumar Thimmulappa

Rajesh Kumar Thimmulappa currently holds 1 directorship: Fytomed Life Private Limited (Director, since 09 Mar 2022).

Rajesh Kumar Thimmulappa was first appointed on 09 Mar 2022 as Director at Fytomed Life Private Limited.

The current boards of Rajesh Kumar Thimmulappa's companies include Mudnakudu Nagaraju Kiran Kumar (Fytomed Life Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available